Oncternal Therapeutics Inc (ONCT): From last ER, May 9, 2015: "The Company...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Oncternal Therapeutics Inc (ONCT)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	11
Posts	388
Boards Moderated	0
Alias Born	01/12/2014

Re: boss143 post# 651

Tuesday, 06/16/2015 10:04:17 PM

Tuesday, June 16, 2015 10:04:17 PM

From last ER, May 9, 2015:
"The Company is also developing GTx-758 (Capesaris ), an oral nonsteroidal selective ER alpha agonist, for the treatment of advanced prostate cancer.
The Company is presently conducting a Phase 2 clinical trial evaluating GTx-758 as a secondary hormonal therapy in men with metastatic and high risk nonmetastatic
CRPC with data from this clinical trial expected in the third quarter of 2015. The Company does not plan to dedicate further resources to this program after the conclusion of this Phase 2 clinical trial and is currently determining third party interest in partnering or acquiring this asset and other preclinical ER alpha agonist compounds in order to fund additional clinical development."

Notice: "third party interest in partnering or acquiring this asset"
Share price has been on a steady climb...I guess that might be the reason.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ONCT News

Oncternal Therapeutics Announces Updated Safety and Efficacy Data for Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer • GlobeNewswire Inc. • 10/22/2024 01:00:00 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/15/2024 04:12:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 08:49:42 PM
Oncternal Therapeutics Announces Termination of its Clinical Studies and Exploration of Strategic Alternatives • GlobeNewswire Inc. • 09/12/2024 01:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:30:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:10:15 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:17:40 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/08/2024 09:42:09 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 09:20:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:10:10 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 10:02:41 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 11:00:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 11:00:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 11:00:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 11:00:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 09:05:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:00:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:00:25 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:00:24 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:00:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:00:12 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:15:12 PM

More ONCT News

InvestorsHub NewsWire

FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM

Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM

Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM

Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM

Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow